Insider Purchases: Inside the Buy
Tag: #FUNanc1al
CEO Buys Alarm.com Stock: Time To Rush In or Panic?
Alarm.com is back on investors’ radar after a rare CEO insider buy and a tidal wave of institutional ownership. With growing SaaS revenue, real profitability, and a stock still far below its 2021 highs, ALRM may be setting up for a stealth rebound. Here’s the fun, funny, icon-filled breakdown of whether to rush in, hold steady, or panic responsibly.
Insiders Buy Big But Marriott Vacations Worldwide Shareholders Are Far From Merry Yet
Insiders at Marriott Vacations Worldwide are scooping up shares, but the stock’s massive drop, margin contraction, and shaky demand raise big questions. Is VAC a high-risk bargain or a value trap in disguise?
Biohaven Just Went Through Hell — But Its CEO and Directors Still See an Angel
Biohaven’s stock plunged after a brutal FDA rejection — but insiders didn’t blink. They bought millions of dollars’ worth of shares, doubled down on their pipeline, and kickstarted a leaner, more focused strategy. Bold turnaround play or biotech heartburn waiting to happen? Here's the FUNanc1al deep dive.
CEO Buys Shares of Roper Technologies: Knows the Ropes or On the Ropes?
A massive insider buy, a $3B share repurchase program, soaring cash flow, and institutions owning nearly the entire float. Is Roper Technologies signaling deep value—or just tugging on your curiosity rope?
Freshworks Insider Buys: Are FRSH Shares Finally Getting… Fresh?
Freshworks insiders just went shopping — and not for office snacks. The CEO/President and CFO/COO bought shares, hinting that FRSH may finally be ready to rise. Here’s the fun, funny breakdown of why insiders love it… and whether you should too.
New CEO Buys TMUS: Insider Confidence or Lost Contacts?
New T-Mobile CEO Srini Gopalan wasted no time showing confidence — buying nearly $2 million of TMUS stock right after taking charge. With record customer growth, a raised outlook, and juicy cash flow, the question is: smart signal or misdialed enthusiasm? 📱💰
Dexcom’s COO Just Bought ~$1M of Stock — Sweet Signal or Just a Sugar Rush?
Dexcom’s insider buy just spiked the glucose of Wall Street chat rooms. The COO is buying big, AI features are rolling, and institutions own almost everything. Is DXCM a sweet buy or a sugar rush in disguise? 🍬📈
Two Directors Are Buying Clarivate. Should You Buy CLVT?
Two Clarivate directors just made multi-million-dollar insider buys, betting that the data-intelligence firm’s turnaround is for real. The company is paying down debt, buying back shares, and leaning hard into AI-driven analytics. But is this a deep-value opportunity — or just another corporate clarinet solo waiting to go off-key? 🎶
CEO, COB, President All Bought Shares of FTI Consulting (FCN). It’s the Same Person—Still… Should You Buy Too?
FTI Consulting just posted record EPS while its tri-titled chief bought $1.13M of stock and the board added $500M to buybacks. A cycle-balanced franchise that compounds through booms, busts, and boardroom “oh-no’s.”
Cohen & Steers (CNS): Chairman Buys Millions—Time To Clip the Coupon or Clip Your Wings?
CNS shows mid-single-digit revenue growth, double-digit EPS growth, and a fresh $2.85M insider buy. Real-asset optionality, de-foamed multiple, TL;DR + FAQs.